Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cyteir Therapeutics (CYT)
NASDAQ:CYT
RESEARCH TOOLSreports
Cyteir Therapeutics (CYT) Ownership - Who Owns Cyteir Therapeutics?
24 Followers
Cyteir Therapeutics (CYT) Ownership Overview
50.84% Insiders
8.92% Mutual Funds
31.21% Other Institutional Investors
9.03% Public Companies and
Individual Investors
The ownership structure of Cyteir Therapeutics (CYT) stock is a mix of institutional, retail and individual investors. Approximately 40.13% of the company’s stock is owned by Institutional Investors, 50.84% is owned by Insiders and 9.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 19, 2024 | Braden Michael Leonard >10% Owner | Bought | $342469 |
| Mar 05, 2024 | Bought | $17473 | |
| Mar 05, 2024 | Markus Renschler President & Ceo,director | Bought | $35004 |
| Feb 16, 2024 | Jean George Director | Bought | $23914 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,419,670 | Institution | 3.94% | 4,273,207 | |
| 826,758 | Institution | 2.30% | 2,488,542 | |
| 714,923 | Institution | 1.99% | 2,151,918 | |
| 687,391 | Institution | 1.91% | 2,069,047 | |
| 524,050 | Institution | 1.46% | 1,577,391 | |
| 162,424 | Institution | 0.45% | 488,896 | |
| 39,828 | Institution | 0.11% | 119,882 | |
| 32,800 | Institution | 0.09% | 98,728 | |
| 15,972 | Institution | 0.04% | 48,076 | |
| 10,000 | Institution | 0.03% | 30,100 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,419,670 | Institution | 3.94% | 4,273,207 | |
| 826,758 | Institution | 2.30% | 2,488,542 | |
| 687,391 | Institution | 1.91% | 2,069,047 | |
| 162,424 | Institution | 0.45% | 488,896 | |
| 39,828 | Institution | 0.11% | 119,882 | |
| 32,800 | Institution | 0.09% | 98,728 | |
| 15,972 | Institution | 0.04% | 48,076 | |
| 10,000 | Institution | 0.03% | 30,100 | |
| 5,209 | Institution | 0.01% | 15,679 | |
| 5,017 | Institution | 0.01% | 15,101 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 545,089 | Institution | 1.51% | 1,695,227 | |
| 169,834 | Institution | 0.47% | 528,184 |
FAQ
Who Owns Cyteir Therapeutics (CYT)?
According to the latest TipRanks data, approximately 31.21% of the company's stock is held by institutional investors, 50.84% is held by insiders, and 9.03% is held by retail investors.
What percentage of Cyteir Therapeutics (CYT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.21% of Cyteir Therapeutics (CYT) stock is held by institutional investors.
What percentage of Cyteir Therapeutics (CYT) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.03% of Cyteir Therapeutics (CYT) stock is held by retail investors.
Who owns the most shares of Cyteir Therapeutics (CYT)?
Fidelity Advisor Series VII owns the most shares of Cyteir Therapeutics (CYT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.